Literature DB >> 31595880

Aspirin-free antiplatelet regimens after PCI: when is it best to stop aspirin and who could ultimately benefit?

Mariusz Tomaniak1, Robert F Storey, Patrick W Serruys.   

Abstract

Entities:  

Year:  2020        PMID： 31595880     DOI： 10.4244/EIJY19M10_01

Source DB:  PubMed          Journal:  EuroIntervention        ISSN： 1774-024X            Impact factor:   6.534


× No keyword cloud information.
  3 in total

Review 1.  P2Y12 inhibitor monotherapy in patients undergoing percutaneous coronary intervention.

Authors:  Davide Capodanno; Usman Baber; Deepak L Bhatt; Jean-Philippe Collet; George Dangas; Francesco Franchi; C Michael Gibson; Hyeon-Cheol Gwon; Adnan Kastrati; Takeshi Kimura; Pedro A Lemos; Renato D Lopes; Roxana Mehran; Michelle L O'Donoghue; Sunil V Rao; Fabiana Rollini; Patrick W Serruys; Philippe G Steg; Robert F Storey; Marco Valgimigli; Pascal Vranckx; Hirotoshi Watanabe; Stephan Windecker; Dominick J Angiolillo
Journal:  Nat Rev Cardiol       Date:  2022-06-13       Impact factor: 32.419

2.  Efficacy and Safety of Dual Antiplatelet Therapy in Patients Undergoing Coronary Stent Implantation: A Systematic Review and Network Meta-Analysis.

Authors:  Yi Xu; Yimin Shen; Delong Chen; Pengfei Zhao; Jun Jiang
Journal:  J Interv Cardiol       Date:  2021-05-05       Impact factor: 2.279

Review 3.  Early Aspirin Discontinuation Following Acute Coronary Syndrome or Percutaneous Coronary Intervention: A Systematic Review and Meta-Analysis of Randomized Controlled Trials.

Authors:  Paul Guedeney; Jules Mesnier; Sabato Sorrentino; Farouk Abcha; Michel Zeitouni; Benoit Lattuca; Johanne Silvain; Salvatore De Rosa; Ciro Indolfi; Jean-Philippe Collet; Mathieu Kerneis; Gilles Montalescot
Journal:  J Clin Med       Date:  2020-03-03       Impact factor: 4.241
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.